Monday, 17 December 2018

Accord Healthcare recalls diuretics due to labelling mix up

24 September 2018 | News

Accord Healthcare is the US arm of Intas Pharmaceuticals.

Image Credit: productrecall.campaign.gov.uk

Image Credit: productrecall.campaign.gov.uk

Accord Healthcare Inc, the US arm of Intas Pharmaceuticals, is recalling over 46,000 bottles of Hydrochlorothiazide tablets manufactured by the Ahmedabad-based firm, on account of labelling mix-up, USFDA said.

Hydrochlorothiazide tablets belong to a class of drugs known as diuretics and are used for treatment of high blood pressure and edema.

Accord Healthcare is recalling 46,632 bottles of Hydrochlorothiazide tablets USP in the strength of 12.5 mg, the Enforcement Report by United States Food and Drug Administration (USFDA) said.

The reason for the recall is "Labelling: label mix-up: customer complaint that a sealed bottle labelled as Hydrochlorothiazide tablets USP 12.5 mg contained only Spironolactone tablets USP 25 mg," it added.

The voluntary nationwide recall in the US and Puerto Rico has not been classified yet, the report said.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Does Indian Pharma lack an innovation-friendly ecosystem?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls